ライフサイエンスコーパス: omega-3 fatty acid

1 ules, either niacin or salicylic acid, to an omega-3 fatty acid.

2 ial therapeutic and prophylactic benefits of omega-3 fatty acids.

3 tion during the autoxidation of oils rich in omega-3 fatty acids.

4 ed for several covariates, including age and omega-3 fatty acids.

5 tribute to the salutary signaling actions of Omega-3 fatty acids.

6 s observed only in subjects with high plasma omega-3 fatty acids.

7 er of structured triacylglycerols containing omega-3 fatty acids.

8 echanism for the anti-inflammatory effect of omega-3 fatty acids.

9 n risk associated with intakes of long-chain omega-3 fatty acids.

10 ent anti-inflammatory mediators derived from omega-3 fatty acids.

11 total polyunsaturated fatty acids and total omega-3 fatty acids.

12 te LDL cholesterol for fibrates, niacin, and omega-3 fatty acids.

13 drugs, such as antidepressants, lithium and omega-3 fatty acids.

14 ries, and health effects of contaminants and omega-3 fatty acids.

15 ogenesis, which can be reversed with dietary omega-3 fatty acids.

16 r triglycerides include niacin, fibrates and omega-3 fatty acids.

17 LDL-C): fibrates, niacin, and marine-derived omega-3 fatty acids.

18 ing pathway contain higher concentrations of omega-3 fatty acids.

19 ed the use of nortriptyline, sertraline, and omega-3 fatty acids.

20 nity of patients with Alzheimer's disease by omega-3 fatty acids.

21 ing lipid mediators (SPMs) derived from n-3 (omega-3) fatty acids.

22 cy of hyperlipidemia and high intake of n-3 (omega-3) fatty acids.

23 study demonstrated that oral consumption of omega-3 fatty acids (180 mg EPA and 120 mg DHA twice dai

24 Daily multinutrient supplements (1412-mg omega-3 fatty acids, 30-mug selenium, 400-mug folic acid

25 ow fruit consumption (11.5%), and low marine omega-3 fatty acids (9.7%) were associated with the larg

26 eys fed docosahexaenoic acid, the long-chain omega-3 fatty acid abundant in neural membranes, had cor

27 , vitamin D, vitamin B-12, protein, and n-3 (omega-3) fatty acids, all of which have important roles

28 the omega-6 fatty acid linoleic acid and the omega-3 fatty acid alpha-linolenic acid.

29 Eicosapentaenoic acid (EPA), an omega-3 fatty acid and constituent of fish oil, is a com

30 een relational memory accuracy and intake of omega-3 fatty acids and a negative relation of both rela

31 Also, the relative increase in omega-3 fatty acids and alpha-tocopherol, from winter to

32 e effects of 4-17 month supplementation with omega-3 fatty acids and antioxidants (Smartfish drink; S

33 found that food neophobia associations with omega-3 fatty acids and associated metabolites are media

34 nutrient-genotype combinations, particularly omega-3 fatty acids and CFH.

35 Its omega-3 fatty acids and EPA accounted for 33 and 10% of

36 for the association of intakes of individual omega-3 fatty acids and fish with endometrial cancer ris

37 w microalga can be cultivated for long chain omega-3 fatty acids and lutein production in the tropica

38 testinal bleeding among 45 (n = 28 receiving omega-3 fatty acids and n = 17 receiving placebo).

39 The consumption of omega-3 fatty acids and phytosterol promotes the reducti

40 sk, but significantly reduced % RBC membrane omega-3 fatty acids and thinner foveas compared with tho

41 key earlier intervention studies with marine omega-3 fatty acids and to review and comment on recent

42 sociations between intakes of marine-sourced omega-3 fatty acids and UL risk.

43 omarkers that may regulate the metabolism of omega-3 fatty acids and ultimately affect their therapeu

44 as remained unclear why supplementation with omega-3 fatty acids and vitamin D improve cognitive func

45 Plasma concentrations of omega-3 (omega-3) fatty acids and homocysteine are associated wit

46 showed that higher baseline intakes of n-3 (omega-3) fatty acids and leucine are associated with pre

47 in the fresh vine leaves, linolenic acid (an omega-3-fatty acid) and quercetin-3-O-glucuronide (a pol

48 in, magnesium, copper, docosahexaenoic acid, omega-3 fatty acid, and alcohol-and 3 nutrients were ass

49 The benefits of vitamin D, omega-3 fatty acids, and exercise in disease prevention

50 K channels are thus receptors for long-chain omega-3 fatty acids, and these fatty acids--unlike their

51 n higher concentrations of calcium, iron and omega-3 fatty acids; and species from cold thermal regim

52 Although omega-3 fatty acids appear to reduce hospital length of

53 creasing concentrations of vaccenic acid and omega-3 fatty acids, appeared more efficient for organic

54 In addition, plasma levels of omega-3 fatty acids are affected not only by dietary int

55 D ( approximately 70% of the population) and omega-3 fatty acids are common, suggesting that brain se

56 Omega-3 fatty acids are dietary essentials, and the curr

57 Omega-3 fatty acids are essential for healthy brain and

58 tural sources of triacylglycerols containing omega-3 fatty acids are of particular interest due to th

59 Omega-3 fatty acids are used in both nutraceuticals and

60 was Impact (Novartis/Nestle), which contains omega-3 fatty acids, arginine, and nucleotides.

61 In addition, patients in the omega-3 fatty acid arm underwent significant reductions

62 AFLD to (a) establish the dose of long-chain omega-3 fatty acids as a treatment, (b) determine the du

63 ng has practical implications for the use of omega-3 fatty acids as nutraceuticals for the general pu

64 2000 IU per day and marine n-3 (also called omega-3) fatty acids at a dose of 1 g per day for the pr

65 Long-chain omega-3 fatty acids belong to a family of polyunsaturate

66 ew understanding regarding the complexity of omega-3 fatty acid biology is the purpose of this review

67 assigned randomly to lutein and zeaxanthin, omega-3 fatty acids, both, or placebo, and most also rec

68 mperature, revealed by a slight reduction of omega-3 fatty acids, but neither accumulation of TBARS n

69 FFAR4 agonists and omega-3 fatty acids, but not saturated fatty acids, trig

70 e potential for encapsulating and delivering omega-3 fatty acids, but they are typically fabricated f

71 d in a large multicenter study, suggest that omega-3 fatty acids can be an effective, safe, and affor

72 These opposing effects of tissue omega-6 and omega-3 fatty acids can be eliminated by antibiotic trea

73 in docosahexaenoic acid (DHA), an essential omega-3 fatty acid, can constrain freshwater colonizatio

74 e across research with cytokine antagonists, omega-3 fatty acids, celecoxib, and exercise is that ant

75 of Immunity, Yan et al. (2013) suggest that omega-3 fatty acids commonly found in marine oils can su

76 diabetes, supplementation with vitamin D3 or omega-3 fatty acids, compared with placebo, resulted in

77 ent analyses, the fish component of aMED and omega-3 fatty acids component of AHEI-2010 were inversel

78 ermore, the produced echium oil had the same omega-3 fatty acid composition than traditionally extrac

79 We investigated whether plasma omega-3 fatty acid concentrations (eicosapentaenoic acid

80 -3 supplementation raised plasma and adipose omega-3 fatty acid concentrations but had no beneficial

81 Similarly, serum omega-3 fatty acid concentrations were inversely associa

82 s analyzed according to tertiles of baseline omega-3 fatty acid concentrations.

83 ed fat content, and improved unsaturated and omega-3 fatty acid concentrations.

84 of an alteration in the ratio of omega-6 to omega-3 fatty acid consumption are increased production

85 ty acid consumption is markedly greater than omega-3 fatty acid consumption.

86 and the wild type revealed reductions in all omega-3 fatty acid-containing plastidic and extraplastid

87 With minor deviations, omega-3 fatty acid content and lipid class of all produc

88 Adipose and muscle omega-3 fatty acid content increased after treatment; ho

89 e with a codon-optimized CrFAD7 restored the omega-3 fatty acid content of both plastidic and extrapl

90 a plastid-located desaturase may impact the omega-3 fatty acid content of extraplastidic lipids.

91 2.5h, 40 degrees C) successfully doubled the omega-3 fatty acid content to 43.20 mol%.

92 (1)H NMR was used to determine omega-3 fatty acid content, and GC-MS to characterize oi

93 ts received oral supplementation with 4 g of omega-3 fatty acids daily (840 mg eicosapentaenoic acid/

94 ation of bacterial lipopolysaccharides or by omega 3 fatty acid deficient diets), microglia resorted

95 Resolvins are omega-3 fatty acid derived potent bioactive lipids that

96 The host-protective action of omega-3 fatty acid-derived epoxyeicosanoids and speciali

97 d the efficacy of using Maresin 1 (MaR1), an omega-3 fatty acid-derived pro-resolving agent, to resol

98 These results show that CrFAD7 is the only omega-3 fatty acid desaturase expressed in C. reinhardti

99 tion or lentivirus-mediated expression of an omega-3 fatty acid desaturase, mfat-1, normalized blood

100 ice that express the fat-1 gene encoding for omega-3 fatty acid desaturase, which leads to an increas

101 port here that disruption of function of the omega-3 FATTY ACID DESATURASE7 (FAD7) enhances plant def

102 the activities of the microsomal omega-6 and omega-3 fatty acid desaturases, FAD2 and FAD3.

103 analyses identified the relatively innocuous omega-3 fatty acid DHA (docosahexaenoic acid), piracetam

104 Dietary intake of the natural omega-3 fatty acid docosahexaenoic acid (DHA) has been i

105 Dietary and supplemental intake of the omega-3 fatty acid docosahexaenoic acid (DHA) reduces ri

106 We report that the omega-3 fatty acid docosahexaenoic acid (DHA), in combin

107 ched in the visual pigment rhodopsin and the omega-3 fatty acid docosahexaenoic acid (DHA).

108 roduced by cytochrome P450 epoxygenases from omega-3 fatty acid docosahexaenoic acid, inhibit VEGF- a

109 sion of essential fatty acids, including the omega-3 fatty acids docosahexaenoic acid and n-3 docosap

110 sis of a lipid mediator derived from natural omega-3-fatty acid docosahexaenoic acid (DHA), 10 S,17 S

111 Omega-3 fatty acids (docosahexaenoic acid [DHA] and eico

112 of antioxidants, zinc, and carotenoids with omega-3 fatty acids (docosahexaenoic acid and eicosapent

113 The omega-3-fatty acid, docosahexaenoic acid (DHA) 22:6 n-3,

114 hort-term supplementation with high doses of omega-3 fatty acids does not result in any measurable ch

115 e transgenic conversion of tissue omega-6 to omega-3 fatty acids dramatically reduces endotoxemic and

116 We sought to evaluate how omega-3 fatty acids during brain maturation can influenc

117 Dietary enrichment in omega-3 fatty acids during pregnancy and lactation in mi

118 Dietary omega-3 fatty acids (eg, alpha-linolenic acid) were inhi

119 (PGE3), derived from COX-2 metabolism of the omega-3 fatty acid eicosapentaenoic acid (EPA), inhibite

120 The polyunsaturated omega-3 fatty acid eicosapentaenoic acid-derived resolvi

121 t include arachidonic acid-derived lipoxins, omega-3 fatty acid eicosapentaenoic acid-derived resolvi

122 The availability of the omega-3 fatty acids eicosapentaenoic acid (EPA) and doco

123 It remains uncertain whether the omega-3 fatty acids eicosapentaenoic acid (EPA) and doco

124 imental studies suggests that the long-chain omega-3 fatty acids eicosapentaenoic acid and docosahexa

125 The long chain n-3 (omega-3) fatty acids eicosapentaenoic acid (EPA) and doc

126 ween B vitamin treatment and plasma combined omega-3 fatty acids (eicosapentaenoic acid and docosahex

127 omized to receive vitamin D3 (2000 IU/d) and omega-3 fatty acids (eicosapentaenoic acid and docosahex

128 ch source of the health promoting long-chain omega-3 fatty acids, eicosapentaenoic (EPA) and docosahe

129 are modulated by vitamin D and the 2 marine omega-3 fatty acids, eicosapentaenoic acid (EPA) and doc

130 s of arachidonic acid (20:4 omega-6) and the omega-3 fatty acids: eicosapentaenoic acid (22:5) and do

131 fecal transfer revealed that elevated tissue omega-3 fatty acids enhance intestinal production and se

132 vely regulates adiponectin and through which omega-3 fatty acids enhance the anti-inflammatory adipok

133 ocosahexaenoic acid (DHA), a polyunsaturated omega-3 fatty acid enriched in oily fish, contributes to

134 Lipid oxidation is the main hurdle for omega-3 fatty acid enrichment in food and beverages.

135 mprehensive lipidomics, we identify omega-3 (omega-3) fatty acid epoxides as new mast cell-derived li

136 incorporating docosahexaenoic acid (DHA), an omega-3 fatty acid essential for brain development, in l

137 Docosahexaenoic acid (DHA, 22:6n-3) is an omega-3 fatty acid essential for proper brain developmen

138 Supplementation with omega-3 fatty acids ex vivo showed that their action is

139 ns with essential fatty acids, in particular omega-3 fatty acids, exerts protective actions reducing

140 reat analysis, patients randomly assigned to omega-3 fatty acids experienced a significant reduction

141 This article reviews novel approaches for omega-3 fatty acid (FA) therapeutics and the linked mole

142 of randomized, placebo-controlled trials of omega-3 fatty acid (FA) treatment of major depressive di

143 about the combined effects of iron and n-3 (omega-3) fatty acid (FA) supplementation on cognitive pe

144 m 10 muL of whole or skimmed milk containing omega-3 fatty acids (FAs) during 12, 24, 48, 72 and 96 h

145 Dietary fish oils, rich in long-chain n-3 (omega-3) fatty acids (FAs) [e.g., docosahexaenoic acid (

146 g evidence of the beneficial effects of n-3 (omega-3) fatty acids (FAs) on cardiometabolic risk facto

147 recent epidemiological study suggested that omega-3 fatty acid (fish oil) supplementation blunted ca

148 to investigate the therapeutic potential of omega-3 fatty acids for patients with homozygous sickle

149 DESIGN, SETTING, AND PATIENTS: The Omega-3 Fatty Acids for Prevention of Post-operative Atr

150 om 239 patients enrolled in the OPERA trial (Omega-3 Fatty Acids for Prevention of Post-Operative Atr

151 These findings do not support use of this omega-3 fatty acid formulation to reduce major adverse c

152 alpha-Linolenic acid (ALA) is an n-3 (omega-3) fatty acid found mostly in plant foods such as

153 was to evaluate whether intake of long-chain omega-3 fatty acids from diet and supplements is associa

154 Omega-3 fatty acids from fish oil have been associated w

155 have been extensively tested to concentrate omega-3 fatty acids from fish oils, under mild enzymatic

156 Demand for long chain omega-3 fatty acids from non-fish source for vegetarians

157 t have potential to preferentially hydrolyze omega-3 fatty acids from structured triacylglycerols.

158 pathway by which the brain obtains essential omega-3 fatty acids from the circulation is through a so

159 Transfer of n-6 (omega-6) and n-3 (omega-3) fatty acids from the maternal diet into human m

160 mean difference of 0.57 days in favor of the omega-3 fatty acid group (95% confidence interval -5.05,

161 pentaenoic acid; group 1, n = 10) or without omega-3 fatty acids (group 2, n = 10).

162 with HM-lecithin inhibited the oxidation of omega-3 fatty acids >/=90% compared to those stabilized

163 In subjects with high baseline omega-3 fatty acids (>590 mumol/L), B vitamin treatment

164 s study was to investigate the links between omega-3 fatty acids, gut microbiome diversity and compos

165 n contrast, those with low levels of dietary omega-3 fatty acids had decreased functional connectivit

166 Each of these omega-3 fatty acids has distinct biological effects that

167 Higher intake of marine n-3 (also called omega-3) fatty acids has been associated with reduced ri

168 efficacy of nonpharmaceutical interventions (omega-3 fatty acids) has been challenged.

169 Resolvin E1 (RvE1), a SPM derived from omega-3 fatty acids, has been reported to dampen intesti

170 hanistic insights into the actions of marine omega-3 fatty acids have been gained.

171 In contrast, randomized clinical trials of omega-3 fatty acids have yielded mixed and inconsistent

172 Omega-3 fatty acids hold the potential to reduce cardiov

173 ation for absence of reports of lipases with omega-3 fatty acid hydrolyzing ability and suggests meth

174 cosahexanoic acid (DHA) is the most abundant omega-3 fatty acid in brain, and, although it is conside

175 Studies of marine omega-3 fatty acids in atrial fibrillation and in cardia

176 alter the concentration of both omega-6 and omega-3 fatty acids in both mother and offspring, with c

177 Enrichment of omega-3 fatty acids in cod liver oil via alternate opera

178 The OMEMI trial (Omega-3 Fatty acids in Elderly with Myocardial Infarctio

179 ovascular health have been attributed to the omega-3 fatty acids in fish and fish oils, but toxic che

180 gency sources regarding the contaminants and omega-3 fatty acids in Great Lakes fish and fish consume

181 currently available on the concentration of omega-3 fatty acids in Great Lakes fish and their absorp

182 in modulating the metabolism of omega-6 and omega-3 fatty acids in maternal mouse livers.

183 Recent studies testing the effects of omega-3 fatty acids in NAFLD are showing promise and sug

184 icient methodology for the quantification of omega-3 fatty acids in oils rich in omega-6 fatty acids

185 pplements) and non-protein nutrients such as omega-3 fatty acids in regulating MPS.

186 In contrast, data are sparse on omega-3 fatty acids in the fish and their consumers.

187 ckness was inversely associated with dietary omega-3 fatty acids in those with impaired fetal growth

188 Omega-3 fatty acids increase the unfolded protein respon

189 with later ages, and the ratio of omega-6 to omega-3 fatty acids increased in the aged brain (week 56

190 review and meta-analysis was to investigate omega-3 fatty acids' influence on 12 inflammatory biomar

191 Mothers in the lowest 5% of omega-3 fatty acid intake had a significant increase in

192 uggests that optimizing vitamin D and marine omega-3 fatty acid intake may help prevent and modulate

193 In contrast, high marine omega-3 fatty acid intake may improve disease-specific s

194 Omega-3 fatty acid intake was assessed by using a food-f

195 ssociated with both forms of memory, whereas omega-3 fatty acid intake was selectively positively ass

196 nges associated with differences in lifetime omega-3 fatty acid intake.

197 ay be a viable natural emulsifier to deliver omega-3 fatty acids into food and beverage products.

198 Oxidation of omega-3 fatty acids is a major limitation on its enrichm

199 Dietary intake of omega-3 fatty acids is associated with a slower rate of

200 Increased self-reported dietary intake of omega-3 fatty acids is associated with reduced risk of G

201 ential of membrane processing to concentrate omega-3 fatty acids is enhanced.

202 Consumption of long-chain omega-3 fatty acids is known to decrease the risk of maj

203 However, the role of omega-3 fatty acids is unclear.

204 nd serotonergic systems to sleep quality and omega-3 fatty acid levels.

205 drugs known to mitigate suicidality, such as omega-3 fatty acids, lithium and clozapine.

206 of atrophy among subjects with low baseline omega-3 fatty acids (<390 mumol/L).

207 However, oral supplementation with omega-3 fatty acids, lutein plus zeaxanthin, zinc, or be

208 ment effect was not significantly different (omega-3 fatty acids main effect HR, 1.18; 95% CI, 0.96-1

209 Probiotics and omega-3 fatty acids may ameliorate disease progression.

210 We conclude that omega-3 fatty acids may be associated with lower inflamm

211 Omega-3 fatty acids may influence human physiological pa

212 se results suggest that intake of long-chain omega-3 fatty acids may reduce risk of total and cancer-

213 There was an increase in total omega 3 fatty acids (n-3) in muscle tissue (from 63.6 to

214 Whether marine omega-3 fatty acid (n-3 FA) or vitamin D supplementation

215 itamin D3 and placebo (n = 333), placebo and omega-3 fatty acids (n = 289), or 2 placebos (n = 320) f

216 emulsions are important delivery systems of omega-3 fatty acids (n-3 FA).

217 The long-chain omega-3 fatty acids (n-3 FAs) docosahexaenoic acid (DHA)

218 Heart Association scientific statement, the omega-3 fatty acids (n-3 FAs) eicosapentaenoic acid (EPA

219 Omega-3 fatty acids (n-3 PUFAs) are essential for the fu

220 ts exposed to diets enriched or deficient in omega-3 fatty acids (n-3) during their brain maturation

221 ontents and decrease in the content of total omega-3 fatty acids (n-3) in comparison to raw fish fill

222 ndomly assigned 1:1 to 6 months of high-dose omega-3 fatty acids (n=180) or placebo (n=178).

223 have frequently focused on methylmercury and omega-3 fatty acids, not persistent pollutants such as p

224 Omega-3 fatty acids (O3-FAs) can be effective in decreas

225 on other factors including dietary intake of omega-3 fatty acids, obesity, and genotypes at CFH Y402H

226 ase in unsaturated fatty acid content namely omega-3 fatty acids of wheat chips samples.

227 teine-Arginine-Glutamic-acid-Lysine-Alanine) omega-3-fatty acid oil containing nanoemulsion system in

228 Early trials evaluating the effect of omega 3 fatty acids (omega-3 FA) reported benefits for m

229 We previously showed omega-3 fatty acid (omega-3)-mediated repair of unfolded

230 It is well known that the omega-3 fatty acids (omega-3-FAs; also known as n-3 fatt

231 Omega-3 fatty acids (omega-3s) in vitro and in vivo and

232 id beta1-42 (Abeta1-42), but are improved by omega-3 fatty acids (omega-3s).

233 s been well ascertained, the position of the omega-3 fatty acid on the triacylglycerol backbone influ

234 humans with FOs and measured the effects of omega-3 fatty acids on adipocytes and macrophages in vit

235 ed the effects of high-dose, very-long-chain omega-3 fatty acids on adipose tissue inflammation and i

236 also suggested that the beneficial effect of omega-3 fatty acids on brain atrophy may be confined to

237 e differential effects of tissue omega-6 and omega-3 fatty acids on gut microbiota and metabolic endo

238 Recent studies of marine omega-3 fatty acids on morbidity of, and mortality from,

239 d pro-resolving lipid mediators derived from omega-3 fatty acids or arachidonic acid and by relevant

240 result in either lower levels of long-chain omega-3 fatty acids or higher levels of long-chain omega

241 ole of mixed meals or carbohydrate, protein, omega-3 fatty acid, or antioxidant supplementation in mi

242 en V249I and rs2669845 and dietary intake of omega-3 fatty acids (P = .004 and P = .009, respectively

243 Furthermore, the benefits of marine-derived omega-3 fatty acids, particularly high-dose eicosapentae

244 nd macaque brain and support the notion that omega-3 fatty acids play a crucial role in developing an

245 However omega-3 fatty acid preferences were found to be modest.

246 Diatoms are a major group of high omega 3-fatty acid producing algae that play a key role

247 ders and suicidality (lithium, clozapine and omega-3 fatty acids), providing a means toward pharmacog

248 TULP3-dependent ciliary localization of the omega-3 fatty acid receptor FFAR4/GPR120 promotes adipog

249 A study confirmed that marine omega-3 fatty acids reduce the inflammatory burden with

250 The addition of omega-3 fatty acids reduced MCP-1 expression with no eff

251 ne whether supplementation with vitamin D or omega-3 fatty acids remediates pain, changes frequency o

252 Dietary supplementation with 4 g of omega-3 fatty acids results in a significant increase in

253 lternative medicines (including acupuncture, omega-3 fatty acids, S-adenosyl-L-methionine, St. John's

254 We propose that dietary omega-3 fatty acids selectively drive expansion of adipo

255 However, no lipases with preference for omega-3 fatty acids selectivity have yet been discovered

256 immune-modulating nutrients (eg, glutamine, omega-3 fatty acids, selenium, and antioxidants) has bee

257 trient composition of seafood, in particular omega-3 fatty acids, selenium, taurine, vitamins D and B

258 als with low to medium risk of bias compared omega-3 fatty acids, soy, ginkgo biloba, B vitamins, vit

259 Evidence about effects of omega-3 fatty acids, soy, ginkgo biloba, folic acid alon

260 (SCARB1, ABCA1, ABCG5, and LIPC), long-chain omega-3 fatty acid status (ELOVL2, FADS1, and FADS2), an

261 serum dietary carotenoids and long-term RBC omega-3 fatty acid status, as well as common secondary c

262 on with FOLate, vitamins B-6 and B-12 and/or OMega-3 fatty acids (SU.FOL.OM3) trial was a secondary p

263 Long-chain omega-3 fatty acids such as docosahexaenoic acid (DHA) r

264 Long-chain polyunsaturated omega-3 fatty acids such as docosahexaenoic acid (DHA),

265 dings do not support the use of vitamin D or omega-3 fatty acid supplementation for preserving kidney

266 systematic review, it can be concluded that omega-3 fatty acid supplementation of parenteral nutriti

267 uch as cardiovascular exercise, acupuncture, omega-3 fatty acid supplementation, and gluten-free diet

268 , compared with parenteral nutrition without omega-3 fatty acid supplementation.

269 kin mediator lipidome in response to dietary omega-3 fatty acid supplementation.

270 Randomized controlled trials of omega-3 fatty acid supplemented parenteral nutrition in

271 p = 0.008) was observed for those receiving omega-3 fatty acid supplemented parenteral nutrition, bu

272 Our findings suggest that omega-3 fatty acid supplements offer protection against

273 In addition, omega-3 fatty acids suppressed the upregulation of adipo

274 Docosahexaenoic acid (DHA) is an essential omega-3 fatty acid that is critical to the formation of

275 d to take advantage of the health beneficial omega 3 fatty acids, the EGCG molecule was esterified wi

276 d clinical trial of lutein/zeaxanthin and/or omega-3 fatty acids, the Age-Related Eye Disease Study 2

277 no adverse events associated with high-dose omega-3 fatty acid therapy.

278 to potentially provide a complex mixture of omega-3 fatty acids to maximize cardiovascular risk redu

279 d meats, and alcohol), and nutrient intakes (omega-3 fatty acids, trans fatty acids, total fiber, and

280 Finally, we discuss the role of omega-3 fatty acids transported by lipoproteins in gener

281 Omega-3 fatty acid treatment may have beneficial effects

282 Docosahexaenoic acid (DHA) is a omega-3 fatty acid typically obtained from the diet or e

283 (95% CI, -13.3 to -11.1) mL/min/1.73 m2 with omega-3 fatty acids vs -13.1 (95% CI, -14.2 to -12.0) mL

284 h acute myocardial infarction with high-dose omega-3 fatty acids was associated with reduction of adv

285 A significant presence of the most important omega-3 fatty acids was detected.

286 Overall desaturase activity measured with omega-3 fatty acids was higher in C-allele carriers.

287 ever, the content of total chemically intact omega-3 fatty acids was higher in the oil released from

288 mutant with more than 65% reduction in total omega-3 fatty acids was isolated by screening an inserti

289 n between the severity of food neophobia and omega-3 fatty acids was replicated in all cross-sectiona

290 Omega-3 fatty acids were also incorporated into skin in

291 High baseline omega-3 fatty acids were associated with a slower rate o

292 Estimated food intake of omega-3 fatty acids were obtained from food frequency qu

293 (HL and SL), whereas DHA and EPA, a valuable omega-3 fatty acid, were the major PUFAs in aquatic orig

294 Echium oil is rich in omega-3 fatty acids, which are important because of thei

295 Fish oil contains a complex mixture of omega-3 fatty acids, which are predominantly eicosapenta

296 ical options, including regular exercise and omega-3 fatty acids, which could be helpful for improvin

297 hain fatty acids, including health-promoting omega-3 fatty acids, which have been implicated in the r

298 supplemental eicosapentanoic acid (EPA), an omega-3 fatty acid with immune and anabolic properties,

299 ignificant immune and biochemical effects of omega-3 fatty acids with antioxidants in patients with M

300 monstrates that BK channels are effectors of omega-3 fatty acids with marked tissue specificity.